Yahoo! Finance: Drug Manufacturers - Major Industry News

Santarus Reports Strong Quarter (Zacks.com)

Sun, 8 Nov 2009 01:43:34 Etc/GMT

Santarus, Inc. reported third-quarter earnings of 9 cents per share, surpassing the Zacks Consensus Estimate at a loss of 1 cent

[$$] Boston Scientific to Settle (at The Wall Street Journal Online)

Sat, 7 Nov 2009 05:04:52 Etc/GMT

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 (Business Wire)

Sat, 7 Nov 2009 01:15:00 Etc/GMT

LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif.----GlaxoSmithKline and XenoPort, Inc. today announced that the U.S. Food and Drug Administration has extended the original Prescription Drug User Fee Act goal date for its review of the New Drug Application for GSK1838262/XP13512 to February 9, 2010.

No Product Revenues, Plenty of Risk: Buy Exelixis? (at CNBC)

Sat, 7 Nov 2009 00:57:09 Etc/GMT

Living Without Blockbusters (at Forbes.com)

Fri, 6 Nov 2009 23:41:47 Etc/GMT

Alcon Boosts Presence In Eye Disease Market (Investor's Business Daily)

Fri, 6 Nov 2009 23:39:18 Etc/GMT

Ophthalmic drug and device maker Alcon eyes big returns from a pair of deals it signed over the past two months.

Making the Flu Vaccine (CNBC)

Fri, 6 Nov 2009 20:28:13 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/25/68/16.jpg/yfinance/cnbc2/Economics/1321327706http://www.cnbc.com/http://l.yimg.com/us.yimg.com/i/us/fi/gr/partner_logos/cnbc_1.png

Aceto Corporation Q1 2010 Earnings Call Transcript (at Seeking Alpha)

Fri, 6 Nov 2009 20:12:07 Etc/GMT

Alliance Data Systems plans move to Plano (at bizjournals.com)

Fri, 6 Nov 2009 20:05:18 Etc/GMT

Boston Scientific Sets $296 Million Settlement on Devices (at The Wall Street Journal Online)

Fri, 6 Nov 2009 18:30:02 Etc/GMT

What Not To Wear At Sanofi-Pasteur (at CNBC)

Fri, 6 Nov 2009 16:01:08 Etc/GMT

NuVasive appoints new CFO and other executives (AP)

Fri, 6 Nov 2009 15:47:54 Etc/GMT

Medical-device company NuVasive Inc. said Friday that it named Michael Lambert as its chief financial officer, succeeding Kevin O'Boyle.

Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors (Wall Street Transcript)

Fri, 6 Nov 2009 15:33:00 Etc/GMT

Par 3Q profit surges on product sales (AP)

Fri, 6 Nov 2009 14:49:05 Etc/GMT

Generic drugmaker Par Pharmaceutical Companies Inc. said Friday its profit surged in the third quarter on a boost in product sales.

Under the Flu Vaccine Veil (CNBC)

Fri, 6 Nov 2009 13:53:59 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/25/67/15.jpg/yfinance/cnbc2/Government/1321121093http://www.cnbc.com/http://l.yimg.com/us.yimg.com/i/us/fi/gr/partner_logos/cnbc_1.png

Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST (PR Newswire)

Fri, 6 Nov 2009 13:30:00 Etc/GMT

Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray (Wall Street Transcript)

Fri, 6 Nov 2009 13:18:00 Etc/GMT

67 WALL STREET, New York - November 6, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Ariad's 3Q loss widens slightly on costs (AP)

Fri, 6 Nov 2009 13:07:44 Etc/GMT

Drug developer Ariad Pharmaceuticals Inc. said Thursday its third-quarter loss widened slightly on overall costs as it continues developing potential cancer treatments.

Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call (Business Wire)

Fri, 6 Nov 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals, Inc. , a commercial-stage biotechnology company with a focus in oncology, today announced the date and time for its third quarter 2009 corporate update and pipeline review conference call.

Aceto Announces Fiscal 2010 First Quarter Results of Operations (GlobeNewswire)

Fri, 6 Nov 2009 11:55:00 Etc/GMT

LAKE SUCCESS, N.Y. -- Aceto Corporation , a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of chemically derived pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced results of operations for its fiscal 2010 first quarter ended September 30, 2009.